Mandy Moody, CFE
ACFE Social Media Specialist
“No matter where you are in your career, you will benefit from this conference.” “To have such a wide variety of topics and individuals is truly unique.” “There is something for everybody.” These are just a handful of the comments I recently heard when conducting video interviews with some of our ACFE faculty about the ACFE Global Fraud Conference. I hear feedback like this regularly, some solicited and some not. The selection of concurrent sessions, Pre- and Post-Conference sessions and keynotes is diverse; it spans industries, job levels, interests and even career goals. This year we will have more than 70 concurrent sessions to choose from and five keynote sessions I am excited to announce.
Here is the lineup so far:
- Louis Freeh, Former Director, FBI, “Corporate America's Top Investigator”
Dubbed “the singularly best-suited person in America to run the FBI” by former New York City Mayor Rudolph Giuliani, Freeh has been heralded for transforming the FBI into a global security institution. During his eight-year tenure, he visited 62 countries and met with more than 2,000 foreign leaders while increasing the FBI’s focus on counterintelligence, cybercrime and electronic surveillance. Freeh has kept his investigation skills sharp through his involvement in several high-profile cases with Penn State, MF Global and BP.
- Peter Eigen, Founder, Transparency International
Prof. Dr. Peter Eigen has worked in economic development and governance for several decades and has led initiatives for better global governance and the fight against corruption.
- Martin Kenney, International Asset Recovery Expert
Kenney's work as a global asset chaser has resulted in recovering billions of dollars in ill-gotten gains from fraudsters; he is widely regarded as a groundbreaker in his field.
- Marc Goodman, Global Strategist, Cyber Security Expert, Senior Advisor, Interpol Steering Committee on Information Technology Crime
Over the past 20 years, Goodman has built his expertise in security threats such as cybercrime and cyber terrorism, working with organizations such as Interpol, the United Nations and NATO.
- Dinesh Thakur, Ranbaxy Whistleblower
Eighty percent of prescriptions dispensed in the U.S. contain foreign sourced ingredients and more than 40 percent of the prescriptions are fully manufactured overseas. Former Ranbaxy Laboratories (an India based pharma company) executive Dinesh Thakur discovered that the company was falsifying drug data and violating current good manufacturing and laboratory practices in order to gain competitive advantage in the U.S. market. His eight-year collaboration with the U.S. FDA and the Department of Justice to unravel the dangerous fraud led to a 2013 guilty plea by Ranbaxy and a groundbreaking $500 million settlement, the largest of its kind against a generic drug manufacturer.
I look forward to seeing you and nearly 3,000 anti-fraud professionals from around the world at the 25th Annual ACFE Global Fraud Conference in San Antonio, June 15-20, 2014. Find session topics, networking details and more at FraudConference.com. Don’t forget, last year’s conference sold out; register early by April 1 so you don’t miss your chance to attend.